Neural Activity

3

Review clinical trials related to Neural Activity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Whole-Brain Dynamics in the Natural Menstrual Cycle vs. an Ovarian Stimulated Cycle: Impact of Hormonal Fluctuations on Healthy Women Undergoing Ovarian Stimulation

The investigators aim is to investigate the brain's dynamic complexity across three phases of an ovarian stimulation cycle (basal, pre-OPU, mid-luteal), to observe the impact of externally administered hormones, and compare it with the corresponding phases of a natural menstrual cycle (early follicular, pre-ovulatory, mid-luteal) in the same woman. Brain activity patterns will be examined using resting-state fMRI in a sample of young, healthy, naturally cycling women.

Participants needed: 15
Trial details
Age: 25-35Biological sex: FemaleType: ObservationalSponsor: ART Fertility Clinics LLCUpdated: Jun 23, 2026Locations: 2Duration: 8 Weeks
Eligibility criteria

Age group: 25 - 35 years old [+5]

History of ovarian surgery [+4]

Status: Not yet recruiting

Probiotics for Depressive Symptomatology and Neural Activity.

This study aims to investigate the acute and chronic effects of 16-week probiotic supplementation (Ecologic® Barrier) on depressive symptoms and neural activity in those with mild-to-moderate depression.

Participants needed: 76
Trial details
Age: 25-40Biological sex: AllType: InterventionalSponsor: University of ReadingUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

Mild to moderate depression symptoms (BDI-II 12-28) [+3]

Taking antidepressants (up to 2 months prior to inclusion) [+9]

Status: Recruiting

Contraceptive Hormone and Reward Measurement (CHARM Study)

Purpose of this study: The purpose of this study is to learn more about how hormonal oral contraceptives affect brain processes and emotional wellbeing. Procedures: If participants agree to participate, the following will happen: 1. Eligibility visit (remote screening session) 2. If participants are eligible to participate in the study, they will be placed in one of two groups. If they are in the first group, they will be asked to take an oral contraception pill ("study drug") every day for 21 days. If they are in the second, they will take a placebo every day for 21 days. A placebo is a pill that looks like medicine but is not real and will have no medical effect on participants. Participants will not get to choose which group they are in, nor will they be told which group they are in. 3. During the three-week period in which participants will take either the study drug or placebo, they will be asked to complete daily check-in surveys on their computer or mobile device. 4. Participants will be asked to attend two additional visits over the course of about three weeks. At these visits, participants will be asked to undergo a urine drug screen, a blood draw, and a magnetic resonance imaging (MRI). They will also be asked to complete behavioral questionnaires.

Participants needed: 144
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of Colorado, DenverUpdated: Nov 4, 2024Locations: 1
Eligibility criteria

Aged 18 and older; [+9]

Presence or history of severe or unstable physical, neurological (per health his... [+20]